Alderaan Biotechnology
Paris
About Alderaan Biotechnology
Alderaan Biotechnology is a Biotechnology company develops antibodies targeting new and original targets in immuno-oncology, expressed by NK cells in particular.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $22.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2020)
- Website: alderaan-biotechnology.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/alderaan-biotechnology-169419 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.